ADC Therapeutics

1 follower

‌

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Industries

Biotechnology

Headquarters

Lausanne, Switzerland

Employees

201-500

Links

Org chart

Ameet Mallik

CEO

Ameet Mallik

Collapse

Kimberly Pope

Chief People Officer

Patrick van Berkel

Chief Scientific Officer

Michael Mulkerrin

Retired

Peter Graham

Chief Legal Officer

Jose Carmona

Chief Financial Officer

Kristen Harrington-Smith

Chief Commercial Officer

Mohamed Zaki

Chief Medical Officer

Jada Baijnath

Director Of Strategic Planning And Chief Of Staff

Jay Feingold

Chief Medical Officer And Senior Vice President

Stephen Dudek

Director, Global Strategy & Lifecycle Management

Jesse Stromeyer

Executive Director, Head Of Marketing

Niall McConnell

Head, Business Information Systems

Ruchi Mallya

Forecasting & Commercial Data Analytics

Jason Moss

Head, Chemical Development & Manufacturing

Teams

+13

Leadership Team

16 members

Clinical Operations and Development

12 members

Finance and Accounting

11 members

Offices

Similar companies

Neuralink

62 followers

Alexion Pharmaceuticals

35 followers

Cytokinetics

12 followers

Oxford Nanopore Technologies

8 followers

Roche

273 followers

Seres Therapeutics

3 followers

Travere Therapeutics

2 followers

53 followers

Scandit

17 followers

World Health Organization

16 followers

University of Toronto

17 followers

Explore companies